Sporotrichosis: a retrospective evaluation of 23 cases seen in northern California (1987-2007).
Sporotrichosis is an uncommon to rare cutaneous and subcutaneous mycosis of animals and humans caused by the dimorphic fungus Sporothrix schenckii. Twenty-three mammalian cases of sporotrichosis examined between 1987 and 2007 at the University of California, Davis - Veterinary Medical Teaching Hospital, were retrospectively evaluated with regard to the historical, clinical, diagnostic and treatment findings. Cats were the most common species affected (n = 14). In addition, sporotrichosis was diagnosed in four dogs, four horses and a donkey. Six of 23 cases were diagnosed with the localized cutaneous form of sporotrichosis (four cats, one dog, one horse), 10 with the cutaneous-lymphatic form (four cats, two dogs, three horses and a donkey), and seven with the disseminated form (six cats, one dog). Two of 23 cases did not have skin lesions at the time of diagnosis (one cat, one dog). The most common mode of diagnosis was demonstration of S. schenckii on histopathological evaluation of tissue. In contrast with most previously described sporotrichosis infections in cats, few to no fungal organisms were seen in histopathological samples (haematoxylin and eosin and special stains) in five of the 14 cats. Treatments received included itraconazole (12 cats, one dog), ketoconazole (three dogs), fluconazole (one cat, one donkey), sodium iodide (four horses, one cat) and potassium iodide (one cat, one horse, one donkey). The prognosis for successful treatment was good in all species. Fluconazole was successful in inducing resolution of the cutaneous lesions and controlling the infection in one cat with disseminated sporotrichosis.
Crothers
Samantha L
SL
Department of Medicine and Epidemiology, Veterinary Medical Teaching Hospital, University of California, Davis, California 95616, USA. scrothers@vmth.ucdavis.edu
White
Stephen D
SD
Ihrke
Peter J
PJ
Affolter
Verena K
VK
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D002140:California / Q000453:epidemiology; D002371:Cat Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology; D002415:Cats; D004283:Dog Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology; D004285:Dogs; D018397:Equidae; D005260:Female; D008297:Male; D012189:Retrospective Studies; D013174:Sporotrichosis / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000662:veterinary*
D000935:Antifungal Agents